Extensively expressed in the central and peripheral nervous systems7,8, VIP2R is involved in a number of pathophysiological conditions, showing a great potential as a therapeutic target for pulmonary arterial hypertension, chronic obstructive pulmonary disease (COPD), cancer, asthma, autoimmune and psychiatric disorders9–12. Here, VIPR2 is linked to pulmonary arterial hypertension.